Vedana Therapeutics
Vedana Therapeutics is developing long-acting biologic medicines to prevent migraine by targeting PACAP and other pathways beyond CGRP. Its therapies are intended for people whose migraine is not adequately controlled by current treatments.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology Research
- Employees
- 19
- Stage
- Series A
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Vedana Therapeutics
Helion’s $465M Series G Values Everett Fusion Firm Above $15B, Tops Seattle-Area 2Q VC Deals
Everett fusion-energy company Helion led greater Seattle-area 2Q venture capital deals with a $465 million Series G that valued it above $15 billion, making up nearly one-third of the region’s $1.5 billion in 2Q funding amid a year-over-year decline from $2.3 billion in 2Q 2025.
Vedana Therapeutics Raises $46M Series A Led by Westlake BioPartners and Canaan Partners for Migraine Therapy Development
Vedana Therapeutics, a Seattle-based biotech company focused on migraine prevention therapies, raised $46 million in a Series A funding round. The round was led by Westlake BioPartners and Canaan Partners, with participation from Dawn Biopharma.
Seattle Biotech Vedana Therapeutics Raises $46 Million to Develop Injectable Migraine Treatments
Seattle biotech Vedana Therapeutics raised $46 million in funding to develop injectable migraine treatments and plans to start Phase 1 trials next year under CEO Anurag Agarwal. The company has launched out of stealth mode to pursue its migraine therapy development.
People
-
Anurag Agarwal Founder & CEO
-
Leon Garcia Founder & CSO
-
Ernesto Aycardi Executive, CMO
Online
Questions about Vedana Therapeutics
What is Vedana Therapeutics?
Vedana Therapeutics is a startup developing long-acting biologic medicines to prevent migraine by targeting PACAP and other pathways beyond CGRP. Based in Seattle, Washington, USA, it is developing therapies for people whose migraine is not adequately controlled by current treatments.
What has Vedana Therapeutics been in the news for?
Puget Sound Business Journal reported in June 2026 that Vedana Therapeutics was developing injectable migraine treatments.
Who are the people behind Vedana Therapeutics?
Anurag Agarwal is founder and CEO of Vedana Therapeutics, and Leon Garcia is founder and CSO. Ernesto Aycardi is an executive and CMO.
Who invested in Vedana Therapeutics, and how much has it raised?
Members of Seattle Flow see Vedana Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Vedana Therapeutics based?
Vedana Therapeutics is based in Seattle, Washington, USA.
How many people work at Vedana Therapeutics?
Vedana Therapeutics has 19 employees.